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Our laboratory has demonstrated that mildly cool hous-
ing temperatures, (a stress known to be mediated by
sympathetic nerve activity and b-adrenergic receptors)
can significantly enhance the incidence, growth, and
metastasis of tumors in murine models by suppressing
anti-tumor immunity [1]. Furthermore, we have shown
that mild cool stress also decreases the sensitivity of
cancer cells to several types of chemo- and targeted
therapeutics [2]. These data strongly suggest that base-
line responses of mouse models of tumor growth and
tumor immunology may be significantly influenced by
housing temperature and the degree of adrenergic stress
experienced by tumor bearing mice. We have now
become interested in dissecting the mechanisms by
which increased adrenergic stress signaling resulting
from cool housing conditions impacts anti-tumor immu-
nity and the response of tumors to therapeutics. To
investigate the effects of increased adrenergic signaling
on anti-tumor immunity, we used b-AR antagonists (b-
blockers) to block b-AR signaling resulting from mild
cold stress induced by housing temperatures. The addi-
tion of a b-blocker to these mice significantly delayed
tumor growth, and recapitulated the increased tumor
growth control observed in mice housed at thermoneu-
trality where cold stress is alleviated. However, b-AR
blockade did not alter tumor growth in mice housed at
thermoneutrality compared to vehicle controls, suggest-
ing that b-AR signaling is responsible for the impair-
ment of anti-tumor immunity in chronically cold
stressed mice. To further investigate the effects of b-AR
signaling on suppressing anti-tumor immunity, we
repeated these experiments in immunodeficient SCID
mice and demonstrated that b-blockers had no effect on
tumor growth in mice regardless of housing tempera-
ture. We also examined the effects of adrenergic stress
signaling on radio-resistance. We addressed this
question by stimulating b-ARs on Pan02 (murine) and
Mia-PACA2 (human) pancreatic tumor cells and per-
formed clonogenic assays. Those cells treated with a
b-agonist exhibited improved survival and proliferation
at varying doses of radiation when compared to
untreated controls similar to our earlier studies using
chemotherapy. In summary, b-adrenergic receptor activ-
ity appears to play a fundamental role in the regulation
of both anti-tumor immunity as well as intrinsic thera-
peutic sensitivity. Therefore, strategic combinations of
b-receptor antagonists with chemo-radiation therapy, or
immunotherapy may provide significantly improved
tumor control. This work was supported by the Peter
T. Rowley Breast Cancer Research Grant and the Harry
J. Lloyd Charitable Trust.
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